929095-51-2 Usage
Description
(R)-Methyl 5-(6-((4-Methylpiperazin-1-yl)Methyl)-1H-benzo[d]iMidazol-1-yl)-3-(1-(2-(trifluoroMethyl)phenyl)ethoxy)thiophene-2-carboxylate is a complex organic compound characterized by its unique molecular structure, which includes benzodiazole, piperazine, thiophene, and carboxylate functional groups. (R)-Methyl 5-(6-((4-Methylpiperazin-1-yl)Methyl)-1H-benzo[d]iMidazol-1-yl)-3-(1-(2-(trifluoroMethyl)phenyl)ethoxy)thiophene-2-carboxylate holds potential pharmacological properties and is of interest in the field of medicinal chemistry due to its diverse functional groups and structural complexity.
Uses
Used in Pharmaceutical Industry:
(R)-Methyl 5-(6-((4-Methylpiperazin-1-yl)Methyl)-1H-benzo[d]iMidazol-1-yl)-3-(1-(2-(trifluoroMethyl)phenyl)ethoxy)thiophene-2-carboxylate is used as a potential pharmaceutical candidate for the development of new drugs. Its unique structure and functional groups may contribute to its interaction with various biological targets, making it a promising compound for further research and development in the treatment of various diseases.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (R)-Methyl 5-(6-((4-Methylpiperazin-1-yl)Methyl)-1H-benzo[d]iMidazol-1-yl)-3-(1-(2-(trifluoroMethyl)phenyl)ethoxy)thiophene-2-carboxylate is used as a starting material or a structural component in the design and synthesis of novel therapeutic agents. Its diverse functional groups and structural features allow for modifications and optimizations to enhance its pharmacological properties and bioavailability.
Please note that the specific applications and reasons for using (R)-Methyl 5-(6-((4-Methylpiperazin-1-yl)Methyl)-1H-benzo[d]iMidazol-1-yl)-3-(1-(2-(trifluoroMethyl)phenyl)ethoxy)thiophene-2-carboxylate are not explicitly provided in the materials. The uses listed above are inferred based on the compound's potential pharmacological properties and its relevance to the fields of pharmaceuticals and medicinal chemistry. Further research and development would be required to determine its specific applications and effectiveness in various therapeutic areas.
Check Digit Verification of cas no
The CAS Registry Mumber 929095-51-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,9,0,9 and 5 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 929095-51:
(8*9)+(7*2)+(6*9)+(5*0)+(4*9)+(3*5)+(2*5)+(1*1)=202
202 % 10 = 2
So 929095-51-2 is a valid CAS Registry Number.
929095-51-2Relevant articles and documents
Methods For The Treatment of Central Nervous System Tumors
-
, (2009/01/24)
Methods for the treatment of primary and secondary central nervous system tumors in a mammal which comprise administration of a benzimidazole thiophene compound are provided.
Regioselective synthesis of benzimidazole thiophene inhibitors of polo-like kinase 1
Hornberger, Keith R.,Badiang, Jennifer G.,Salovich, James M.,Kuntz, Kevin W.,Emmitte, Kyle A.,Cheung, Mui
scheme or table, p. 6348 - 6351 (2009/04/07)
A regioselective synthesis of novel 1-(2-thienyl)-benzimidazole inhibitors of polo-like kinase 1 is described. Amination of substituted 2-iodo or -bromo nitrobenzenes with a 2-aminothiophene derivative catalyzed by Pd2dba3 and XANTPH
BENZIMIDAZOLE THIOPHENE COMPOUNDS
-
Page/Page column 58, (2010/11/26)
The present invention provides benzimidazole thiophene compounds pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.
